| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 03/01/2012 | US20120052008 Nanostructures comprising radioisotopes and/or metals |
| 03/01/2012 | US20120052004 Carbon nanotube based magnetic resonance image contrast agents |
| 03/01/2012 | DE102010036261A1 New peptide having a length of two to five monomers, where the monomers are an alpha hydroxy-4(1H)-pyridinone compounds, useful to treat metal (preferably iron, copper or aluminum) storage disorders, preferably siderosis |
| 03/01/2012 | CA2807543A1 Method for producing phenyl-substituted heterocyclic derivative by means of coupling method using a palladium compound |
| 02/29/2012 | EP2423204A1 Thiazolidinone derivative |
| 02/29/2012 | EP2423190A1 Compounds Exhibiting PGD 2 Receptor Antagonism |
| 02/29/2012 | EP2422817A1 Flavin-nucleic acid ligand conjugates |
| 02/29/2012 | EP2422814A1 Remedy for cartilage-related diseases |
| 02/29/2012 | EP2422813A1 Agent for regulating composition ratio of intestinal bacterial flora |
| 02/29/2012 | EP2422785A1 Method for predicting therapeutic effect of chemotherapy on renal cell cancer |
| 02/29/2012 | EP2422779A1 Selective ep4 receptor agonistic substance for treatment of cancer |
| 02/29/2012 | EP2407175A9 Agents with angiogenic and wound healing activity |
| 02/29/2012 | EP1953148B1 Heterocyclic amide compound and use thereof |
| 02/29/2012 | EP1669350B1 Piperidine derivatives |
| 02/29/2012 | EP1662007B9 Preventive or remedy for inflammatory bowel diseases containing anti-cd81 antibody as the active ingredient |
| 02/29/2012 | EP1465642B1 Protection against the neurotoxicity of oxaliplatin through the administration of calcium and magnesium |
| 02/29/2012 | EP1311269B1 Method of using diketopiperazines and composition containing them |
| 02/29/2012 | EP1248604B2 Combinations comprising dipeptidylpeptidase-iv inhibitors and antidiabetic agents |
| 02/29/2012 | EP1002091B1 Nucleic acid sequence and method for selectively expressing a protein in a target cell or tissue |
| 02/29/2012 | CN102365281A Indolizine derivative and use thereof for medical purposes |
| 02/29/2012 | CN102365269A Novel therapeutic agent for cognitive impairment |
| 02/29/2012 | CN102365093A Prophylactic or therapeutic agent for retinal diseases and method for preventing or treating retinal diseases, each comprising jnk (c-jun n-terminal kinase)-inhibiting peptide, and use of the peptide |
| 02/29/2012 | CN102363770A Recombinant baculovirus capable of expressing porcine circovirus type 2 Cap protein and somatostatin in fusion manner, and subunit vaccine thereof |
| 02/29/2012 | CN102362855A Itraconazole isomer oral liquid |
| 02/29/2012 | CN102038785B Detection method for traditional Chinese medicinal preparation of children eyesight pills |
| 02/29/2012 | CN101679309B Novel pyrimidine compound having dibenzylamine structure, and medicine comprising the compound |
| 02/29/2012 | CN101657205B Agent for preventing bleeding from cerebral cortical vein |
| 02/29/2012 | CN101400659B Novel 1,2,3,4-tetrahydroquinoxaline derivative having glucocorticoid receptor binding activity |
| 02/28/2012 | US8124638 Tricyclic compounds useful as angiotensin II agonists |
| 02/28/2012 | US8124614 Steroidal compounds for inhibiting steroid sulphatase |
| 02/28/2012 | US8124590 Biodegradable immunomodulatory formulations and methods for use thereof |
| 02/28/2012 | US8124586 Prevention and reduction of blood loss |
| 02/28/2012 | US8124378 Murine zcytor17 ligand polynucleotides |
| 02/28/2012 | US8124134 Isolation of a dual COX-2 and 5-lipoxygenase inhibitor from Acacia |
| 02/28/2012 | US8124133 Total coumarins include six active compounds, which have been identified as osthal, xanthotoxol xanthotoxin, isopimpinellin, bergapten, imperatorine; little side-effect |
| 02/28/2012 | US8124122 Female hormone-containing patch |
| 02/28/2012 | US8124081 Using amyloid A specific immunoglobulin for use in prevention and treatment of infection, nervous system, cell proliferative and inflammatory disorders |
| 02/28/2012 | US8124070 Probiotics for pet food applications |
| 02/28/2012 | US8123707 Method and apparatus for connective tissue treatment |
| 02/28/2012 | CA2219361C Human antibodies derived from immunized xenomice |
| 02/23/2012 | WO2012024637A2 Ethyl pyruvate compositions and methods |
| 02/23/2012 | WO2012023631A1 Pharmaceutical composition for inhibiting proliferation of cancer cells which comprises heat shock protein (hsp) and eci301 polypeptide, and cancer treatment method using same |
| 02/23/2012 | WO2012023600A1 4-isopropyl-6-methoxyphenyl glucitol compound |
| 02/23/2012 | WO2012023597A1 Composition containing tetracyclic compound |
| 02/23/2012 | WO2012023582A1 4-isopropylphenyl glucitol compound |
| 02/23/2012 | WO2012023345A1 Method and composition for treating, preventing and diagnosing cancer containing cancer stem cells or derived therefrom |
| 02/23/2012 | WO2012023301A1 Novel plant-derived immunostimulating agent |
| 02/23/2012 | US20120046354 Anti-oxidant lozenges for the prevention and treatment of radiation induced mucositis, precancerous lesions, oral cancer and other oral cavity mucosal disorders |
| 02/23/2012 | US20120046340 Down Regulation of the Gene Expression by Means of Nucleic Acid-Loaded Virus-Like Particles |
| 02/23/2012 | US20120046325 Isoxazoline Compounds Having MIF Antagonist Activity |
| 02/23/2012 | US20120046263 Method to alter sex ratios in avian offspring |
| 02/23/2012 | US20120046219 Melanocortin receptor-specific peptides |
| 02/23/2012 | US20120046217 TNF-alpha Antagonists Containing IGFBP5 |
| 02/23/2012 | US20120045501 Connexin enhances chemotherapy-included apoptosis in human cancer cells inhibiting tumor cell proliferation |
| 02/23/2012 | US20120045482 Policosanol nanoparticles |
| 02/23/2012 | US20120045454 2,4-pyrimidinediamine compounds and their uses |
| 02/23/2012 | US20120045429 Methods and Agent for Modulating the RNA Polymerase II-Histone Surface |
| 02/23/2012 | US20120045424 Assembly, device kit and method for preparing platelet-rich plasma (prp) |
| 02/23/2012 | US20120045420 Compositions and improved soft tissue replacement methods |
| 02/23/2012 | DE102010039489A1 Konzentrat Concentrate |
| 02/23/2012 | CA2808210A1 Composition comprising tetracyclic compound |
| 02/22/2012 | EP2420501A1 Novel compound having 3-heteroarylpyrimidin-4-(3h)-one structure and pharmaceutical preparation containing same |
| 02/22/2012 | EP2420490A1 (+)-2-[1-(3-Ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione: Methods of using and compositions thereof |
| 02/22/2012 | EP2420247A1 Adenovirus formulations |
| 02/22/2012 | EP2420239A2 Antiangiogenic agents |
| 02/22/2012 | EP2420238A2 Anti-angiogenic agents |
| 02/22/2012 | EP2420236A2 Anti-angiogenic agents |
| 02/22/2012 | EP2420230A2 Antiangiogenic agents |
| 02/22/2012 | EP2419408A1 3-aryl or heteroaryl-substituted indole derivative |
| 02/22/2012 | EP2419401A2 GAMMA-AMINO-BUTYRIC ACID DERIVATIVES AS GABAb RECEPTOR LIGANDS |
| 02/22/2012 | EP2419398A1 A prodrug comprising beta-keto carboxylic acid, beta-keto carboxylic acid salt or beta-keto carboxylic acid ester for drug delivery |
| 02/22/2012 | EP2419097A1 Pharmaceutical compositions |
| 02/22/2012 | EP1626049B1 Microcrystal of (E)-8-(3,4-dimethoxystyryl)-1,3-diethyl-7-methyl-3,7-dihydro-1H-purine-2,6-dione |
| 02/22/2012 | EP1541151B1 REMEDY FOR GLAUCOMA COMPRISING Rho KINASE INHIBITOR AND PROSTAGLANDINS |
| 02/22/2012 | EP1534289B2 Adenosine a2a receptor antagonists for treating restless legs syndrome or nocturnal myoclonus |
| 02/22/2012 | EP1524975B9 Improved transdermal delivery system for the administration of rotigotine |
| 02/22/2012 | EP1514542B1 Medicinal composition comprising Tacrine or Donepezil for improving brain function. |
| 02/22/2012 | EP1507778B1 Anti-tumour polycyclic carboxamides |
| 02/22/2012 | EP1163029B1 Nitrate esters and their use for inducing neuroprotection and cognition enhancement |
| 02/22/2012 | EP0986384B1 Inhibitors of protein isoprenyl transferases |
| 02/22/2012 | CN1854151B 多巴胺转运蛋白拟肽抑制剂及其应用 Peptidomimetic inhibitor of dopamine transporter and its application |
| 02/22/2012 | CN102361638A Transdermal preparation |
| 02/22/2012 | CN102358752A GLP-1 and exendin related invention |
| 02/22/2012 | CN102358730A Micromolecular methyl ethyl ketone (MEK) protein kinase inhibitor |
| 02/22/2012 | CN102357263A Composite inducer for promoting autologous peripheral preadipocyte proliferation and enlargement for cosmesis and body beautification and preparation method thereof |
| 02/22/2012 | CN102008583B 一种能清除体内香烟油及润喉的药物及其制备方法 One kind of body can eliminate cigarette oil and throat medicine and its preparation method |
| 02/22/2012 | CN101906395B 一种口服免疫阻断鸡肌抑素作用的转化子及其应用 An oral immunization of chicken myostatin blocking effect of transformation and its application |
| 02/22/2012 | CN101492416B 影响葡糖激酶的化合物 Effect of compound of glucokinase |
| 02/21/2012 | US8119819 Malonyl-CoA decarboxylase inhibitors useful as metabolic modulators |
| 02/21/2012 | US8119691 Method for treating airway hyper-responsiveness with lipoxin analogs |
| 02/21/2012 | US8119678 Compounds, compositions and methods |
| 02/21/2012 | US8119649 Use of c-Src inhibitors alone or in combination with STI571 for the treatment of leukaemia |
| 02/21/2012 | US8119631 Inhibitors of interleukin-1β converting enzyme |
| 02/21/2012 | US8119619 Pregnane steroids and their use in the treatment of CNS disorders |
| 02/21/2012 | US8119395 Vaccines, immunotherapeutics and methods for using the same |
| 02/21/2012 | US8119163 Nanoparticulate and controlled release compositions comprising cefditoren |
| 02/21/2012 | CA2488372C Pyridazine derivatives which are phosphodiasterase iv inhibitors |
| 02/21/2012 | CA2472399C Pharmaceutical compositions comprising valsartan and nep inhibitors |
| 02/21/2012 | CA2444031C 3,4-di-substituted cyclobutene-1,2-diones as cxc-chemokine receptor ligands |
| 02/21/2012 | CA2418962C Anti-dual integrin antibodies, compositions, methods and uses |